CAPITAL FUND MANAGEMENT S.A. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
CAPITAL FUND MANAGEMENT S.A. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$3,295,259,000
-0.2%
103,138
+8.2%
0.03%
+11.1%
Q1 2022$3,301,434,000
+815.5%
95,307
+673.5%
0.03%
+800.0%
Q4 2021$360,635,000
-5.3%
12,321
-17.6%
0.00%0.0%
Q3 2021$380,798,000
+165464.3%
14,945
+232.1%
0.00%
-25.0%
Q1 2020$230,000
-58.3%
4,500
-35.2%
0.00%0.0%
Q4 2019$552,000
+146.4%
6,941
+50.5%
0.00%
+100.0%
Q3 2019$224,000
-86.7%
4,612
-89.6%
0.00%
-77.8%
Q3 2018$1,688,00044,4130.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2022
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders